Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.4152
S.4152: A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced May 5, 2022
- Latest Major Action May 5, 2022
Bill Sponsor
Bill Version
- Introduced in Senate - May 5, 2022
Bill Summary
This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| May 5, 2022 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| May 5, 2022 |
Introduced in the Senate by Mark Kelly (D-Ariz.) |